The activation of immune checkpoint pathways, such as Programmed Death-1 (PD-1)/Programmed Death- Ligand 1 (PD-L1) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), represents a crucial mechanism by which tumor cells evade immune surveillance (2). The gene discussed is CTLA4; the disease is neoplasm.